RPG Life Sciences to deploy Rs 500 crore in next 12 months to bolster manufacturing, API capabilities
Kort samengevat
RPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acquisitions, Managing Director Ashok Nair said. The drugmaker has committed Rs 700 crore for expansion and targets Rs 2,000-2,500 crore revenue by 2030, supported by domestic and international growth.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij The Economic Times.
Lees het volledige bericht ↗